Nano-X Imaging (NNOX) Net Margin (2022 - 2026)
Nano-X Imaging (NNOX) posted quarterly Net Margin of 327.37% for Q1 2026, up 14904.0% year-on-year from N/an in Q1 2025, and up 66.88% on a QoQ basis from 988.46% in Q4 2025.
Nano-X Imaging (NNOX) Net Margin (2022 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported Net Margin for 5 consecutive years, with 327.37% the latest figure, recorded in Q1 2026.
- Quarterly Net Margin rose 14904.0% year-over-year to 327.37% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 546.28% (down 6803.0% YoY) and the FY2025 annual result came in at 209.46%, down 7999.0% from the prior year.
- Net Margin grew to 327.37% in Q1 2026 per NNOX's latest filing, from 988.46% in the prior quarter.
- Over the last five years, Net Margin for NNOX reached as high as 327.37% in Q1 2026 and fell as low as 2575.09% in Q4 2022.
- A 5-year average of 750.65% and a median of 488.31% in 2023 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2023 — Net Margin jumped 214097 bps — and 2025, when it slumped 51350 bps.
- Year by year, Net Margin stood at 2575.09% in 2022, then jumped by 83 bps to 434.13% in 2023, then fell by 9 bps to 474.97% in 2024, then sank by 108 bps to 988.46% in 2025, then jumped by 67 bps to 327.37% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 327.37%, 988.46%, and 402.44% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 16.74% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.01% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nano-X Imaging | 67.53 Mn | 23.68 Mn | -2.59 Mn | -327.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -327.37% |
| Dec 31, 2025 | -988.46% |
| Sep 30, 2025 | -402.44% |
| Jun 30, 2025 | -478.88% |
| Mar 31, 2025 | -476.41% |
| Dec 31, 2024 | -474.97% |
| Sep 30, 2024 | -456.19% |
| Jun 30, 2024 | -508.60% |
| Mar 31, 2024 | -486.84% |
| Dec 31, 2023 | -434.13% |
| Sep 30, 2023 | -869.75% |
| Jun 30, 2023 | -679.24% |
| Mar 31, 2023 | -488.31% |
| Dec 31, 2022 | -2,575.09% |
| Sep 30, 2022 | -817.15% |
| Jun 30, 2022 | -1,082.27% |
| Mar 31, 2022 | -1,214.93% |